| Blood (Leukemia) |
Chemotherapy with or without Blinatumomab for B-Cell Acute Lymphoblastic Leukemia |
E1910 |
| Blood (Leukemia) |
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia |
E1912 |
| Blood (Leukemia) |
Simplified Patient Care Strategy in Decreasing Early Death in Patients with Acute Promyelocytic Leukemia |
EA9131 |
| Blood (Lymphoma) |
Rituximab and Chemotherapy with or without Lenalidomide for Diffuse Large B-Cell Lymphoma |
E1412 |
| Blood (Lymphoma) |
Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in High-Risk Follicular Lymphoma |
E2408 |
| Blood (Lymphoma) |
Rituximab with or without Stem Cell Transplant for Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission |
EA4151 |
| Blood (Myeloma) |
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma |
E1A11 |
| Breast |
Exemestane with or without Entinostat for Patients with Recurrent Hormone Receptor-Positive Breast Cancer that is Locally Advanced or Metastatic |
E2112 |
| Breast |
Value of Breast MRI to Treat Patients Diagnosed with Ductal Carcinoma In Situ |
E4112 |
| Breast |
Testing Platinum-based Chemotherapy after Surgery in Triple-negative Breast Cancers |
EA1131 |
| Breast |
Comparison of 3D Mammography to Abbreviated Breast MRI in Women with Dense Breasts |
EA1141 |
| Breast |
Reducing Chemotherapy-Induced Neuropathy in African American Patients with Breast Cancer |
EAZ171 |
| Breast |
Trial Assigning Individualized Options for Treatment |
TAILORx/PACCT-1 |
| Colorectal |
Financial Burden Assessment in Patients with Stage 1-3 Colon or Rectal Cancer Undergoing Treatment |
EAQ162CD |
| Head and Neck |
Chemotherapy with or without Bevacizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
E1305 |
| Head and Neck |
Transoral Surgery and Low-Dose Radiation Therapy for Oropharynx Cancer |
E3311 |
| Head and Neck |
Testing the Addition of Chemotherapy to the Treatment of Cancer of the Sinonasal Area |
EA3163 |
| Kidney |
Pazopanib Hydrochloride in Treating Patients with Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery |
E2810 |
| Kidney |
Testing the Addition of the Drug Nivolumab Before and After Surgery for Renal Cell Cancer |
PROSPER RCC/EA8143 |
| Lung |
Comparing Two Approaches to Using Antibody Therapy to Treat Stage 3 Non-Small Cell Lung Cancer Which Cannot Be Removed by Surgery |
EA5181 |
| Melanoma (Skin) |
Ipilimumab or High-Dose Interferon Alfa-2b for Treating High-Risk Stage 3-4 Melanoma Removed by Surgery |
E1609 |
| Melanoma (Skin) |
Testing the Therapy Sequence for Advanced BRAF Mutation Melanoma |
DREAMseq/EA6134 |
| Pancreas |
Comparing Two Treatment Combinations for Older Patients with Pancreatic Cancer that has Spread |
GIANT/EA2186 |
| Pancreatic Neuroendocrine Tumors |
Temozolomide with or without Capecitabine for Treating Advanced Pancreatic Neuroendocrine Tumors |
E2211 |
| Prostate |
Androgen Deprivation Therapy with or without Chemotherapy in Treating Metastatic Prostate Cancer |
CHAARTED/E3805 |
| Prostate |
Testing the Addition of Cabazitaxel to Abiraterone for Metastatic Prostate Cancer in Patients Who Have Had Docetaxel |
CHAARTED2/EA8153 |
| Various |
Implementing a Virtual Tobacco Treatment in Community Oncology Practices (Smoke Free Support Study 2) |
EAQ171CD |
